Maren Høland recently received the degree of Master of Science by the University of Oslo, Institute for Molecular Biosciences. In her masters project Maren investigated in situ expression of 11 different protein markers and their prognostic value in malignant peripheral nerve sheath tumors. The main findings were the identification of two different immunohistochemical protein expression profiles that could distinguish a high risk patient group from a low risk group, even among patients in complete remission.
The M.Sc. project was supervised by Dr. Matthias Kolberg and Prof Ragnhild A. Lothe (co-supervisor).
Maren has recently received a PhD grant from the Institute of Clinical Medicine, University of Oslo, and will work in the Lothe group at the Centre for Cancer Biomedicine.
Gudiño V, Bartolomé-Casado R, Salas A(2025) Single-cell omics in inflammatory bowel disease: recent insights and future clinical applications Gut, 74(8), 1335-1345 DOI 10.1136/gutjnl-2024-334165, PubMed 39904604
Panagopoulos I, Andersen K, Lloret I, Gorunova L, Lobmaier I(2025) Novel FRMD6::PTH chimera in tumorous bone lesion carrying a t(4;11;14;12)(q35;p15;q22;q13) Pathol Oncol Res, 31, 1612096 DOI 10.3389/pore.2025.1612096, PubMed 40641561
Kranjec C, Oftedal TF, Ovchinnikov KV, da Silva Duarte V, Hermansen S, Kaus-Drobek M, Sabała I, Porcellato D, Carlsen H, Kjos M(2025) An antibiotic-free antimicrobial combination of bacteriocins and a peptidoglycan hydrolase: in vitro and in vivo assessment of its efficacy Appl Environ Microbiol, e0243324(in press) DOI 10.1128/aem.02433-24, PubMed 40552825